Michael N Starnbach

age ~59

from Boston, MA

Also known as:
  • Michael G Starnbach
  • Mike N Starnbach
  • Michael Starnbach Neal
  • Michael H
Phone and address:
200 Brookline Ave UNIT 1602, Boston, MA 02215

Michael Starnbach Phones & Addresses

  • 200 Brookline Ave UNIT 1602, Boston, MA 02215
  • Swans Island, ME
  • Mount Desert, ME
  • Seattle, WA
  • 304 Country Way, Needham, MA 02492 • 7814499212
  • Cincinnati, OH
  • Stanford, CA
  • Ellsworth, ME

Us Patents

  • Chlamydia Antigens

    view source
  • US Patent:
    20100260791, Oct 14, 2010
  • Filed:
    Aug 1, 2008
  • Appl. No.:
    12/671250
  • Inventors:
    Darren E. Higgins - Jamaica Plain MA, US
    Todd Gierahn - Brookline MA, US
    Michael N. Starnbach - Needham MA, US
    Nadia R. Roan - San Francisco CA, US
  • Assignee:
    President and Fellows of Harvard - Cambridge MA
  • International Classification:
    A61K 39/118
    C07K 14/195
    C07K 7/08
    A61K 38/16
    A61K 38/08
    A61P 37/04
  • US Classification:
    4241901, 530326, 530350, 530327, 514 212, 530328, 530329, 514 216, 4241921, 4242631
  • Abstract:
    p-00010000
  • Compositions For And Methods Of Identifying Antigens

    view source
  • US Patent:
    20110076288, Mar 31, 2011
  • Filed:
    Feb 21, 2007
  • Appl. No.:
    12/224074
  • Inventors:
    Darren E. Higgins - Jamaica Plain MA, US
    Michael N. Starnbach - Needham MA, US
    Todd Gierahn - Brookline MA, US
    Nadia R. Roan - San Francisco CA, US
  • Assignee:
    President and Fellows of Harvard College - Cambridge MA
  • International Classification:
    A61K 39/02
    C40B 40/02
    C40B 40/06
    C40B 30/06
    A61K 38/00
    C07K 14/00
    C07K 14/295
  • US Classification:
    4241841, 506 14, 506 16, 506 10, 514 11, 530350, 530326
  • Abstract:
    Replicable libraries having discrete members in defined locations for screening for antigens to a pathogenic organism are provided. Also provided are methods for using such libraries as well as a specific antigen, CT788, which induces T-cell activation during a infection.
  • Use Of Toxin Peptides And/Or Affinity Handles For Delivering Compounds Into Cells

    view source
  • US Patent:
    20030202989, Oct 30, 2003
  • Filed:
    Apr 8, 1999
  • Appl. No.:
    09/077439
  • Inventors:
    R. JOHN COLLIER - WELLESLEY MA, US
    STEVEN R. BLANKE - HOUSTON TX, US
    JILL C. MILNE - BROOKLINE MA, US
    ERICKA L. BENSON - KALAMAZOO MI, US
    JIMMY D. BALLARD - NORMAN OK, US
    MICHAEL N. STARNBACH - NEEDHAM MA, US
  • International Classification:
    A61K039/02
    C12P021/04
    C12N001/21
    C07K014/195
    C07H021/04
    C12N015/74
  • US Classification:
    424/236100, 514/012000, 530/350000, 435/069700, 435/320100, 435/252300, 536/023700
  • Abstract:
    A method and compositions for delivering a compound to the cytoplasm of a cell are disclosed. The compound to be delivered may be an antigenic compound, may be linked to a polycationic affinity handle, or both. In one of the methods disclosed, the B moiety of a toxin, such as the anthrax PA polypeptide, is also provided to enhance delivery of the compound to the cytoplasm of the cell.
  • Nanoparticle-Based Compositions

    view source
  • US Patent:
    20200215179, Jul 9, 2020
  • Filed:
    Nov 11, 2019
  • Appl. No.:
    16/679920
  • Inventors:
    - Cambridge MA, US
    - Boston MA, US
    Michael N. Starnbach - Needham MA, US
    Robert S. Langer - Newton MA, US
    Omid C. Farokhzad - Waban MA, US
    Ulrich Von Andrian - Chestnut Hill MA, US
  • International Classification:
    A61K 39/118
    A61K 39/02
    A61K 39/04
    A61K 31/711
    A61K 39/085
    A61K 45/06
    A61K 39/09
    A61K 31/4745
  • Abstract:
    Provided herein are new compositions including an inactivated pathogen and one or more adjuvant-loaded polymeric nanoparticles, wherein the adjuvant-loaded nanoparticles are bound to the inactivated pathogen. These compositions are useful for preventing and/or treating diseases caused by the specific pathogens, especially when administered to a subject's mucosal membranes.
  • Compositions For And Methods Of Identifying Antigens

    view source
  • US Patent:
    20190032041, Jan 31, 2019
  • Filed:
    Feb 12, 2018
  • Appl. No.:
    15/894537
  • Inventors:
    - Cambridge MA, US
    Michael N. STARNBACH - Needham MA, US
    Todd GIERAHN - Brookline MA, US
    Nadia R. ROAN - San Francisco CA, US
  • International Classification:
    C12N 15/10
    G01N 33/50
    A61K 39/00
    C07K 14/295
    A61K 38/00
    C12Q 1/68
    C12Q 1/70
  • Abstract:
    Replicable libraries having discrete members in defined locations for screening for antigens to a pathogenic organism are provided. Also provided are methods for using such libraries as well as a specific antigen, CT788, which induces T-cell activation during a infection.
  • Targeted Cytosolic Delivery Of Antigenic Compounds

    view source
  • US Patent:
    20180117144, May 3, 2018
  • Filed:
    Apr 11, 2016
  • Appl. No.:
    15/565752
  • Inventors:
    - Cambridge MA, US
    R. John COLLIER - Wellesley MA, US
    Catarina V. NOGUEIRA - Somerville MA, US
    Michael STARNBACH - Needham MA, US
  • Assignee:
    President and Fellows of Harvard College - Cambridge MA
  • International Classification:
    A61K 39/385
  • Abstract:
    The invention relates to engineered anthrax toxin compositions that can target antigen-presenting cells such as dendritic cells. Specifically, the compositions comprise (a) a native-receptor-ablated anthrax toxin protective antigen (PA) fused to a receptor-binding moiety specific for a target receptor on a dendritic cell and (b) a lethal factor (LF) or a fragment thereof fused to an active moiety comprising at least one repeat of a disease-specific antigen. The invention also relates to methods of using these compositions for targeted delivery to dendritic cells, methods of enhancing CTL activation, and methods of inducing an immune response to cancers, bacteria, and/or viruses.
  • Compositions For And Methods Of Identifying Antigens

    view source
  • US Patent:
    20160090589, Mar 31, 2016
  • Filed:
    May 6, 2015
  • Appl. No.:
    14/705815
  • Inventors:
    - Cambridge MA, US
    Michael N. Starnbach - Needham MA, US
    Todd Gierahn - Brookline MA, US
    Nadia R. Roan - San Francisco CA, US
  • International Classification:
    C12N 15/10
  • Abstract:
    Replicable libraries having discrete members in defined locations for screening for antigens to a pathogenic organism are provided. Also provided are methods for using such libraries as well as a specific antigen, CT788, which induces T-cell activation during a infection.
  • Nanoparticle-Based Compositions

    view source
  • US Patent:
    20160008451, Jan 14, 2016
  • Filed:
    Mar 14, 2014
  • Appl. No.:
    14/772695
  • Inventors:
    - Cambridge, MA, US
    - Boston MA, US
    Michael N. STARNBACH - Needham MA, US
    Robert S. LANGER - Newton MA, US
    Omid C. FAROKHZAD - Waban MA, US
    Ulrich Von ANDRIAN - Chestnut Hill MA, US
  • International Classification:
    A61K 39/118
    A61K 39/04
    A61K 39/02
  • Abstract:
    Provided herein are new compositions including an inactivated pathogen and one or more adjuvant-loaded polymeric nanoparticles, wherein the adjuvant-loaded nanoparticles are bound to the inactivated pathogen. These compositions are useful for preventing and/or treating diseases caused by the specific pathogens, especially when administered to a subject's mucosal membranes.

Get Report for Michael N Starnbach from Boston, MA, age ~59
Control profile